{"id":"tp-48313","type":"article-newspaper","title":"Tarsus Pharmaceuticals Revenue Climbs 63.9% to $194.5 Million in Q3","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/48313","datePublished":"2026-11-04T07:06:38.000Z","dateModified":"2026-11-04T07:06:38.000Z","language":"en","abstract":"GAAP earnings per share was -$14.40. Cash, cash equivalents and marketable securities totaled $309.6 million as of Sept. 30.","section":"Business","references":[]}